
|Videos|June 19, 2021
Assessing IOL options for cataract patients
Author(s)OT Staff Reports, Alex Delaney-Gesing
In recognition of Cataract Awareness Month, Fasika Woreta, MD, MPH, discusses IOL options for cataract patients.
Advertisement
Fasika Woreta, MD, MPH, of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, discusses the determining factors and indicators to consider when treating cataract patients with IOLs.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Moorfields study reveals sharp rise in glaucoma burden across the UK
2
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
3
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
4
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
5














































